Biocompatibility and bioactive potential of the NeoMTA Plus endodontic bioceramic-based sealer
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives: This study evaluated the biocompatibility and bioactive potential of NeoMTA Plus mixed as a root canal sealer in comparison with MTA Fillapex. Materials and Methods: Polyethylene tubes filled with NeoMTA Plus (n = 20), MTA Fillapex (n = 20), or nothing (control group, CG; n = 20) were inserted into the connective tissue in the dorsal subcutaneous layer of rats. After 7, 15, 30 and 60 days, the specimens were processed for paraffin embedding. The capsule thickness, collagen content, and number of inflammatory cells (ICs) and interleukin-6 (IL-6) immunolabeled cells were measured. von Kossa-positive structures were evaluated and unstained sections were analyzed under polarized light. Two-way analysis of variance was performed, followed by the post hoc Tukey test (p ≤ 0.05). Results: At 7 days, the capsules around NeoMTA Plus and MTA Fillapex had more ICs and IL-6-immunostained cells than the CG. However, at 60 days, there was no significant difference in the IC number between NeoMTA Plus and the CG (p = 0.1137) or the MTA Fillapex group (p = 0.4062), although a greater number of IL-6-immunostained cells was observed in the MTA Fillapex group (p = 0.0353). From 7 to 60 days, the capsule thickness of the NeoMTA Plus and MTA Fillapex specimens significantly decreased, concomitantly with an increase in the collagen content. The capsules around root canal sealers showed positivity to the von Kossa stain and birefringent structures. Conclusions: The NeoMTA Plus root canal sealer is biocompatible and exhibits bioactive potential.
Abstract
Objectives: This study evaluated the biocompatibility and bioactive potential of NeoMTA Plus mixed as a root canal sealer in comparison with MTA Fillapex. Materials and Methods: Polyethylene tubes filled with NeoMTA Plus (n = 20), MTA Fillapex (n = 20), or nothing (control group, CG; n = 20) were inserted into the connective tissue in the dorsal subcutaneous layer of rats. After 7, 15, 30 and 60 days, the specimens were processed for paraffin embedding. The capsule thickness, collagen content, and number of inflammatory cells (ICs) and interleukin-6 (IL-6) immunolabeled cells were measured. von Kossa-positive structures were evaluated and unstained sections were analyzed under polarized light. Two-way analysis of variance was performed, followed by the post hoc Tukey test (p ≤ 0.05). Results: At 7 days, the capsules around NeoMTA Plus and MTA Fillapex had more ICs and IL-6-immunostained cells than the CG. However, at 60 days, there was no significant difference in the IC number between NeoMTA Plus and the CG (p = 0.1137) or the MTA Fillapex group (p = 0.4062), although a greater number of IL-6-immunostained cells was observed in the MTA Fillapex group (p = 0.0353). From 7 to 60 days, the capsule thickness of the NeoMTA Plus and MTA Fillapex specimens significantly decreased, concomitantly with an increase in the collagen content. The capsules around root canal sealers showed positivity to the von Kossa stain and birefringent structures. Conclusions: The NeoMTA Plus root canal sealer is biocompatible and exhibits bioactive potential.
참고문헌 (39)
- Tomás-Catalá CJ, "Biocompatibility of new pulp-capping materials NeoMTA Plus, MTA Repair HP, and biodentine on human dental pulp stem cells", J Endod, 44, pp.126~132 (2018)
- Cintra LTA, "Cytotoxicity, biocompatibility, and biomineralization of the new high-plasticity MTA Material", J Endod, 43, pp.774~778 (2017)
- Mondelli JAS, "Biocompatibility of mineral trioxide aggregate flow and biodentine", Int Endod J, 52, pp.193~200 (2019)
- Parirokh M, "Mineral trioxide aggregate and other bioactive endodontic cements: an updated overview - Part I: Vital pulp therapy", Int Endod J, 51, pp.177~205 (2018)
- Siboni F, "Properties of NeoMTA Plus and MTA Plus cements for endodontics", Int Endod J, 50(Supplement 2), pp.e83~e94 (2017)
- Slompo C, "Experimental calcium silicate-based cement with and without zirconium oxide modulates fibroblasts viability", Braz Dent J, 26, pp.587~591 (2015)
- Bozeman TB, "Elemental analysis of crystal precipitate from gray and white MTA", J Endod, 32, pp.425~428 (2006)
- Torabinejad M, "Mineral trioxide aggregate: a comprehensive literature review - Part II:Leakage and biocompatibility investigations", J Endod, 36, pp.190~202 (2010)
- McMichael GE, "Dentinal tubule penetration of tricalcium silicate sealers", J Endod, 42, pp.632~636 (2016)
- Siboni F, "Properties of BioRoot RCS, a tricalcium silicate endodontic sealer modified with povidone and polycarboxylate", Int Endod J, 50(Supplement 2), pp.e120~e136 (2017)
- Quintana RM, "Bone tissue reaction, setting time, solubility, and pH of root repair materials", Clin Oral Investig, 23, pp.1359~1366 (2019)
- Tanomaru-Filho M, "Biocompatibility and mineralized nodule formation of NeoMTA Plus and an experimental tricalcium silicate cement containing tantalum oxide", Int Endod J, 50(Supplement 2), pp.e31~e39 (2017)
- Prüllage RK, "Material properties of a tricalcium silicatecontaining, a mineral trioxide aggregate-containing, and an epoxy resin-based root canal sealer", J Endod, 42, pp.1784~1788 (2016)
- Collado-González M, "Biocompatibility of three new calcium silicate-based endodontic sealers on human periodontal ligament stem cells", Int Endod J, 50, pp.875~884 (2017)
- Camilleri J, "Biocompatibility of two commercial forms of mineral trioxide aggregate", Int Endod J, 37, pp.699~704 (2004)
- Tanomaru-Filho M, "Physicochemical properties and bioactive potential of a new epoxy resin-based root canal sealer", Braz Dent J, 30, pp.563~568 (2019)
- Delfino MM, "Immunoinflammatory response and bioactive potential of GuttaFlow bioseal and MTA Fillapex in the rat subcutaneous tissue", Sci Rep, 10, pp.7173~ (2020)
- Silva GF, "Niobium pentoxide as radiopacifying agent of calcium silicate-based material: evaluation of physicochemical and biological properties", Clin Oral Investig, 19, pp.2015~2025 (2015)
- da Fonseca TS, "In vivo evaluation of the inflammatory response and IL-6 immunoexpression promoted by biodentine and MTA Angelus", Int Endod J, 49, pp.145~153 (2016)
- Saraiva JA, "Reduced interleukin-6 immunoexpression and birefringent collagen formation indicate that MTA Plus and MTA Fillapex are biocompatible", Biomed Mater, 13, pp.035002~ (2018)
- de Pizzol Júnior JP, "Matrix metalloproteinase-1 and acid phosphatase in the degradation of the lamina propria of eruptive pathway of rat molars", Cells, 7, pp.e206~ (2018)
- Silva GF, "Zirconium oxide and niobium oxide used as radiopacifiers in a calcium silicate-based material stimulate fibroblast proliferation and collagen formation", Int Endod J, 50(Supplement 2), pp.e95~e108 (2017)
- Hoshino RA, "Physical properties, antimicrobial activity and in vivo tissue response to Apexit Plus", Materials (Basel), 13, pp.E1171~ (2020)
- Holland R, "Reaction of rat connective tissue to implanted dentin tubes filled with mineral trioxide aggregate or calcium hydroxide", J Endod, 25, pp.161~166 (1999)
- Gomes-Filho JE, "A mineral trioxide aggregate sealer stimulated mineralization", J Endod, 35, pp.256~260 (2009)
- Arias-Moliz MT, "The effect of the final irrigant on the antimicrobial activity of root canal sealers", J Dent, 52, pp.30~36 (2016)
- Li Y, "Histamine-induced production of interleukin-6 and interleukin-8 by human coronary artery endothelial cells is enhanced by endotoxin and tumor necrosis factor-alpha", Microvasc Res, 61, pp.253~262 (2001)
- de Oliveira PA, "Cimetidine reduces interleukin-6, matrix metalloproteinases-1 and -9 immunoexpression in the gingival mucosa of rat molars with induced periodontal disease", J Periodontol, 88, pp.100~111 (2017)
- Kang S, "Targeting interleukin-6 signaling in clinic", Immunity, 50, pp.1007~1023 (2019)
- Hashizume M, "The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis", Arthritis (Egypt), 2011, pp.765624~ (2011)
- Silva EJ, "Evaluation of cytotoxicity and physicochemical properties of calcium silicate-based endodontic sealer MTA Fillapex", J Endod, 39, pp.274~277 (2013)
- James SK, "An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease", Am Heart J, 149, pp.619~626 (2005)
- Narazaki M, "The role and therapeutic targeting of IL-6 in rheumatoid arthritis", Expert Rev Clin Immunol, 13, pp.535~551 (2017)
- Noh MK, "Assessment of IL-6, IL-8 and TNF-α levels in the gingival tissue of patients with periodontitis", Exp Ther Med, 6, pp.847~851 (2013)
- Poggio C, "Comparative cytotoxicity evaluation of eight root canal sealers", J Clin Exp Dent, 9, pp.e574~e578 (2017)
- Vitti RP, "Physical properties of MTA Fillapex sealer", J Endod, 39, pp.915~918 (2013)
- Yaltirik M, "Reactions of connective tissue to mineral trioxide aggregate and amalgam", J Endod, 30, pp.95~99 (2004)
- Cintra LT, "Biocompatibility and biomineralization assessment of a new root canal sealer and root-end filling material", Dent Traumatol, 29, pp.145~150 (2013)
- Bueno CR, "Biocompatibility and biomineralization assessment of bioceramic-, epoxy-, and calcium hydroxide-based sealers", Braz Oral Res, 30, pp.e81~ (2016)